Stay updated with breaking news from Systemic Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
11.09.2022 - Veracyte, Inc. (Nasdaq: VCYT) announced that new data from a Phase 3 trial of the multi-center, multi-national, randomized STAMPEDE platform protocol confirm the ability of the company’s Decipher Prostate Genomic Classifier to identify men with ... Seite 1
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe...
Objectives: The objective of the study was to quantify associations between cancer survival and antibiotic exposure before systemic anticancer therapy. Study Design and Setting: This population-based cohort study compares cause-specific survival according to antibiotic exposure before non–immune checkpoint inhibitor (ICI) systemic therapy in patients diagnosed with single primary cancers in New South Wales between 2013 and 2016. Proportional hazards regression was used to control for confounding, with no antibiotic exposure in the six months before non-ICI systemic therapy serving as the com...
Austria: In a new study conducted by Gerda Trutnovsky and team, it was shown that Imiquimod is a secure, efficient, and well-accepted first-line therapy for patients with vulvar high-grade squamous...